Mycophenolate mofetil versus azathioprine in organ transplantation

American Journal of Transplantation

Volumn 9, Issue 12, 2009, Pages 2856-2857

  Cravedi, P ^a   Perna, A ^a   Ruggenenti, P ^a   Remuzzi, G ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; BRONCHIOLITIS OBLITERANS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; EVIDENCE BASED MEDICINE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MICROEMULSION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

AZATHIOPRINE; GRAFT REJECTION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID;

EID: 72449180378     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02853.x     Document Type: Letter

References (7)

1. Germani G, Pleguezuelo M, Villamil F et al. Azathioprine in liver transplantation: A reevaluation of its use and a comparison with mycophenolate mofetil. Am J Transplant 2009 9 : 1725 1731.
2. Remuzzi G, Lesti M, Gotti E et al. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): A randomised trial. Lancet 2004 364 : 503 512.
3. McNeil K, Glanville AR, Wahlers T et al. Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients. Transplantation 2006 81 : 998 1003.
4. Remuzzi G, Cravedi P, Costantini M et al. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: The MYSS follow-up randomized, controlled clinical trial. J Am Soc Nephrol 2007 18 : 1973 1985.
5. Shah S, Collett D, Johnson R et al. Long-term graft outcome with mycophenolate mofetil and azathioprine: A paired kidney analysis. Transplantation 2006 82 : 1634 1639.
6. Knight SR, Russell NK, Barcena L, Morris PJ. Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: A systematic review. Transplantation 2009 87 : 785 794.
7. Shold JD, Kaplan B. AZA/Tacrolimus is associated with similar outcomes as MMF/tacrolimus among renal transplant recipients. Am J Transplant 2009 9 : 1 8.